![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,2-dimethylhydrazine | multiple interactions | ISO | RGD:1553446 | 6480464 | [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ATP6V1D mRNA | CTD | PMID:22206623 | 1-naphthyl isothiocyanate | increases expression | EXP | | 6480464 | 1-Naphthylisothiocyanate results in increased expression of ATP6V1D mRNA | CTD | PMID:25380136 | 1-nitropropane | increases expression | EXP | | 6480464 | 1-nitropropane results in increased expression of ATP6V1D mRNA | CTD | PMID:17070881 | 17alpha-ethynylestradiol | increases expression | ISO | RGD:1553446 | 6480464 | Ethinyl Estradiol results in increased expression of ATP6V1D mRNA | CTD | PMID:17942748 | 17alpha-ethynylestradiol | multiple interactions | ISO | RGD:1553446 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ATP6V1D mRNA | CTD | PMID:17942748 | 17alpha-ethynylestradiol | affects expression | ISO | RGD:1553446 | 6480464 | Ethinyl Estradiol affects the expression of ATP6V1D mRNA | CTD | PMID:17555576 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1553446 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ATP6V1D mRNA | CTD | PMID:17942748 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1553446 | 6480464 | Tetrachlorodibenzodioxin affects the expression of ATP6V1D mRNA | CTD | PMID:21570461 | 2,4-diaminotoluene | increases expression | EXP | | 6480464 | 2, 4-diaminotoluene results in increased expression of ATP6V1D mRNA | CTD | PMID:17070881 | 2,4-dinitrotoluene | affects expression | EXP | | 6480464 | 2, 4-dinitrotoluene affects the expression of ATP6V1D mRNA | CTD | PMID:21346803 | 2,6-diaminotoluene | increases expression | EXP | | 6480464 | 2, 6-diaminotoluene results in increased expression of ATP6V1D mRNA | CTD | PMID:17070881 | 2,6-dinitrotoluene | affects expression | EXP | | 6480464 | 2, 6-dinitrotoluene affects the expression of ATP6V1D mRNA | CTD | PMID:21346803 | 2-acetamidofluorene | increases expression | EXP | | 6480464 | 2-Acetylaminofluorene results in increased expression of ATP6V1D mRNA | CTD | PMID:17070881 | 2-hydroxypropanoic acid | decreases expression | ISO | RGD:1348353 | 6480464 | Lactic Acid results in decreased expression of ATP6V1D mRNA | CTD | PMID:30851411 | 2-methylcholine | affects expression | ISO | RGD:1348353 | 6480464 | beta-methylcholine affects the expression of ATP6V1D mRNA | CTD | PMID:21179406 | 2-nitro-p-phenylenediamine | increases expression | EXP | | 6480464 | 2-nitro-4-phenylenediamine results in increased expression of ATP6V1D mRNA | CTD | PMID:17070881 | 2-nitrofluorene | increases expression | EXP | | 6480464 | 2-nitrofluorene results in increased expression of ATP6V1D mRNA | CTD | PMID:14600272 more ... | 2-nitropropane | increases expression | EXP | | 6480464 | 2-nitropropane results in increased expression of ATP6V1D mRNA | CTD | PMID:17070881 | 3H-1,2-dithiole-3-thione | decreases expression | EXP | | 6480464 | 1, 2-dithiol-3-thione results in decreased expression of ATP6V1D mRNA | CTD | PMID:19162173 | 4,4'-diaminodiphenylmethane | increases expression | EXP | | 6480464 | 4, 4'-diaminodiphenylmethane results in increased expression of ATP6V1D mRNA | CTD | PMID:25380136 | 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one | increases expression | EXP | | 6480464 | 4-N-methyl-N-nitrosamino-1-3-pyridyl-1-butanone results in increased expression of ATP6V1D mRNA | CTD | PMID:14600272 more ... | 4-acetylaminofluorene | increases expression | EXP | | 6480464 | 4-acetylaminofluorene results in increased expression of ATP6V1D mRNA | CTD | PMID:17070881 | 4-nitro-1,2-phenylenediamine | increases expression | EXP | | 6480464 | 1, 2-diamino-4-nitrobenzene results in increased expression of ATP6V1D mRNA | CTD | PMID:17070881 | acrolein | multiple interactions | ISO | RGD:1348353 | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of ATP6V1D mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of ATP6V1D mRNA | CTD | PMID:32699268 | acrylamide | increases expression | EXP | | 6480464 | Acrylamide results in increased expression of ATP6V1D mRNA | CTD | PMID:28959563 | aflatoxin B1 | increases expression | EXP | | 6480464 | Aflatoxin B1 results in increased expression of ATP6V1D mRNA | CTD | PMID:14600272 more ... | aflatoxin B1 | decreases methylation | ISO | RGD:1348353 | 6480464 | Aflatoxin B1 results in decreased methylation of ATP6V1D gene | CTD | PMID:27153756 | aflatoxin B1 | increases expression | ISO | RGD:1348353 | 6480464 | Aflatoxin B1 results in increased expression of ATP6V1D mRNA | CTD | PMID:27153756 | alpha-pinene | multiple interactions | ISO | RGD:1348353 | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of ATP6V1D mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of ATP6V1D mRNA | CTD | PMID:32699268 | anthracen-2-amine | increases expression | EXP | | 6480464 | 2-anthramine results in increased expression of ATP6V1D mRNA | CTD | PMID:23038007 | Aroclor 1254 | decreases expression | ISO | RGD:1553446 | 6480464 | Chlorodiphenyl 54% Chlorine results in decreased expression of ATP6V1D mRNA | CTD | PMID:23650126 | benzo[a]pyrene | increases expression | ISO | RGD:1553446 | 6480464 | Benzoapyrene results in increased expression of ATP6V1D mRNA | CTD | PMID:21715664 | bisphenol A | decreases expression | ISO | RGD:1348353 | 6480464 | bisphenol A results in decreased expression of ATP6V1D mRNA | CTD | PMID:29275510 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of ATP6V1D mRNA | CTD | PMID:25181051 | Brodifacoum | increases expression | EXP | | 6480464 | bromfenacoum results in increased expression of ATP6V1D protein | CTD | PMID:28903499 | cadmium dichloride | increases expression | ISO | RGD:1553446 | 6480464 | Cadmium Chloride results in increased expression of ATP6V1D mRNA | CTD | PMID:30030080 | captan | increases expression | ISO | RGD:1553446 | 6480464 | Captan results in increased expression of ATP6V1D mRNA | CTD | PMID:31558096 | chloropicrin | affects expression | ISO | RGD:1348353 | 6480464 | chloropicrin affects the expression of ATP6V1D mRNA | CTD | PMID:26352163 | clofibric acid | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of ATP6V1D mRNA | CTD | PMID:17602206 | cocaine | affects expression | EXP | | 6480464 | Cocaine affects the expression of ATP6V1D mRNA | CTD | PMID:20187946 | copper(II) sulfate | increases expression | ISO | RGD:1348353 | 6480464 | Copper Sulfate results in increased expression of ATP6V1D mRNA | CTD | PMID:19549813 | CU-O LINKAGE | increases expression | ISO | RGD:1348353 | 6480464 | cupric oxide results in increased expression of ATP6V1D mRNA | CTD | PMID:22077320 | cyclosporin A | increases expression | ISO | RGD:1348353 | 6480464 | Cyclosporine results in increased expression of ATP6V1D mRNA | CTD | PMID:25562108 | dicrotophos | decreases expression | ISO | RGD:1348353 | 6480464 | dicrotophos results in decreased expression of ATP6V1D mRNA | CTD | PMID:28302478 | doxorubicin | increases expression | ISO | RGD:1348353 | 6480464 | Doxorubicin results in increased expression of ATP6V1D mRNA | CTD | PMID:29803840 | ethanol | increases expression | ISO | RGD:1553446 | 6480464 | Ethanol results in increased expression of ATP6V1D mRNA | CTD | PMID:30319688 | ethanol | multiple interactions | ISO | RGD:1553446 | 6480464 | Ethanol affects the expression of and affects the splicing of ATP6V1D mRNA | CTD | PMID:30319688 | ethyl methanesulfonate | increases expression | ISO | RGD:1348353 | 6480464 | Ethyl Methanesulfonate results in increased expression of ATP6V1D mRNA | CTD | PMID:23649840 | finasteride | increases expression | EXP | | 6480464 | Finasteride results in increased expression of ATP6V1D mRNA | CTD | PMID:24136188 | flutamide | increases expression | EXP | | 6480464 | Flutamide results in increased expression of ATP6V1D mRNA | CTD | PMID:24136188 | folic acid | multiple interactions | ISO | RGD:1553446 | 6480464 | [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ATP6V1D mRNA | CTD | PMID:22206623 | folic acid | decreases expression | ISO | RGD:1553446 | 6480464 | Folic Acid results in decreased expression of ATP6V1D mRNA | CTD | PMID:25629700 | folpet | increases expression | ISO | RGD:1553446 | 6480464 | folpet results in increased expression of ATP6V1D mRNA | CTD | PMID:31558096 | furan | increases expression | EXP | | 6480464 | furan results in increased expression of ATP6V1D mRNA | CTD | PMID:26194646 | Heliotrine | increases expression | EXP | | 6480464 | heliotrine results in increased expression of ATP6V1D mRNA | CTD | PMID:32419051 | hydrazine | increases expression | EXP | | 6480464 | hydrazine results in increased expression of ATP6V1D mRNA | CTD | PMID:15370871 | hydrogen peroxide | affects expression | ISO | RGD:1348353 | 6480464 | Hydrogen Peroxide affects the expression of ATP6V1D mRNA | CTD | PMID:20044591 | isotretinoin | decreases expression | ISO | RGD:1348353 | 6480464 | Isotretinoin results in decreased expression of ATP6V1D mRNA | CTD | PMID:20436886 | methyl methanesulfonate | increases expression | ISO | RGD:1348353 | 6480464 | Methyl Methanesulfonate results in increased expression of ATP6V1D mRNA | CTD | PMID:23649840 | N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of ATP6V1D mRNA | CTD | PMID:17602206 | N-nitrosodimethylamine | increases expression | EXP | | 6480464 | Dimethylnitrosamine results in increased expression of ATP6V1D mRNA | CTD | PMID:14600272, PMID:25380136 | N-nitrosomorpholine | increases expression | EXP | | 6480464 | N-nitrosomorpholine results in increased expression of ATP6V1D mRNA | CTD | PMID:19716841 | nefazodone | increases expression | EXP | | 6480464 | nefazodone results in increased expression of ATP6V1D mRNA | CTD | PMID:24136188 | ozone | multiple interactions | ISO | RGD:1348353 | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of ATP6V1D mRNA more ... | CTD | PMID:32699268 | paracetamol | increases expression | ISO | RGD:1348353 | 6480464 | Acetaminophen results in increased expression of ATP6V1D mRNA | CTD | PMID:22230336 | perfluorooctanoic acid | increases expression | EXP | | 6480464 | perfluorooctanoic acid results in increased expression of ATP6V1D mRNA | CTD | PMID:19162173 | pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of ATP6V1D mRNA | CTD | PMID:19162173 | piroxicam | decreases expression | ISO | RGD:1348353 | 6480464 | Piroxicam results in decreased expression of ATP6V1D mRNA | CTD | PMID:21858171 | pregnenolone 16alpha-carbonitrile | increases expression | EXP | | 6480464 | Pregnenolone Carbonitrile results in increased expression of ATP6V1D mRNA | CTD | PMID:19162173 | rac-lactic acid | decreases expression | ISO | RGD:1348353 | 6480464 | Lactic Acid results in decreased expression of ATP6V1D mRNA | CTD | PMID:30851411 | rotenone | increases expression | ISO | RGD:1348353 | 6480464 | Rotenone results in increased expression of ATP6V1D mRNA | CTD | PMID:31648047 | silicon dioxide | increases expression | ISO | RGD:1553446 | 6480464 | Silicon Dioxide results in increased expression of ATP6V1D mRNA | CTD | PMID:29203145 | sodium dichromate | increases expression | EXP | | 6480464 | sodium bichromate results in increased expression of ATP6V1D mRNA | CTD | PMID:25993096 | sodium dichromate | increases expression | ISO | RGD:1553446 | 6480464 | sodium bichromate results in increased expression of ATP6V1D mRNA | CTD | PMID:31558096 | Soman | decreases expression | EXP | | 6480464 | Soman results in decreased expression of ATP6V1D mRNA | CTD | PMID:19281266 | tamoxifen | affects expression | ISO | RGD:1553446 | 6480464 | Tamoxifen affects the expression of ATP6V1D mRNA | CTD | PMID:17555576 | thimerosal | increases expression | ISO | RGD:1348353 | 6480464 | Thimerosal results in increased expression of ATP6V1D mRNA | CTD | PMID:27188386 | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of ATP6V1D mRNA | CTD | PMID:23411599 | trichostatin A | affects expression | ISO | RGD:1348353 | 6480464 | trichostatin A affects the expression of ATP6V1D mRNA | CTD | PMID:28542535 | tunicamycin | decreases expression | ISO | RGD:1348353 | 6480464 | Tunicamycin results in decreased expression of ATP6V1D mRNA | CTD | PMID:29453283 | urethane | increases expression | ISO | RGD:1348353 | 6480464 | Urethane results in increased expression of ATP6V1D mRNA | CTD | PMID:28818685 | valproic acid | increases expression | ISO | RGD:1553446 | 6480464 | Valproic Acid results in increased expression of ATP6V1D mRNA | CTD | PMID:20546886 | valproic acid | increases expression | ISO | RGD:1348353 | 6480464 | Valproic Acid results in increased expression of ATP6V1D mRNA | CTD | PMID:23179753, PMID:29154799 | valproic acid | affects expression | ISO | RGD:1348353 | 6480464 | Valproic Acid affects the expression of ATP6V1D mRNA | CTD | PMID:25979313 | vorinostat | increases expression | ISO | RGD:1348353 | 6480464 | vorinostat results in increased expression of ATP6V1D mRNA | CTD | PMID:27188386 | |